EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase II)Open Access · CC BY 4.0

A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non‐Small Cell Lung Cancer (NEXTAC‐TWO)

Shuichi Mitsunaga iD, Tateaki Naito iD, Hisao Imai, Madoka Kimura, Satoru Miura, Hisashi Tanaka, Takuro Mizukami, Akira Imoto, Chihiro Kondoh, Hiroyuki Okuyama, Makoto Ueno, Shinsuke Shiotsu und 10 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13871 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Shuichi Mitsunaga und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Lung Neoplasms, Exercise Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In our previous study (NEXTAC‐ONE), the Nutrition and Exercise Treatment for Advanced Cancer (NEXTAC) program (including home‐based exercise and branched‐chain amino acid‐containing supplements combined with nutritional counselling) was shown to potentially prevent low muscle mass‐related disability in elderly cancer patients. This randomized controlled trial (NEXTAC‐TWO) was conducted to elucidate whether the NEXTAC program prolongs disability‐free survival in elderly patients with advanced pancreatic or non‐small cell lung cancer.

Methods

This open‐label, multicentre, randomized phase II study was conducted at 15 Japanese hospitals. Patients aged ≥ 70 years, with pathologically proven advanced pancreatic or non‐small cell lung cancer, who were scheduled to undergo systemic chemotherapy for treatment‐naïve tumours were randomly assigned (1:1) to undergo observation or receive the NEXTAC program for 12 weeks. Randomization was performed by the minimization method, using performance status and types with cancer diagnosis and anticancer treatment as adjustment factors. The primary endpoint was disability‐free survival (period from randomization to the date patients were evaluated as needing care or death due to any cause). Key secondary endpoints were change in weight, muscle mass, physical activity, nutritional assessment, safety and survival. This trial was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000028801).

Results

From 2017 to 2019, 131 patients were enrolled and randomly assigned to NEXTAC ( n = 66) or control arms ( n = 65, median age 76.0 years). After randomization, two patients in the NEXTAC arm declined further participation. As a result, 64 patients (median age 75.5 years) received at least one session of the NEXTAC program. The completion rate of the planned exercise and nutrition consultation sessions was 98.4% in the NEXTAC arm. Of the 129 patients, 91 (71%) had a disability (44 in the NEXTAC arm; 47 in the control arm). In the primary analysis, median disability‐free survival periods were 478 days (95% confidence interval [CI], 358–576) in the NEXTAC arm and 499 days in the control arm (95% CI, 363–604), with no significant differences between them ( p = 0.884). The hazard ratio for disability‐free survival in the NEXTAC arm compared with the control arm was 0.970 (95% CI 0.642–1.465). There were no differences in the secondary endpoints between the two arms.

Conclusions

The patients had good compliance with the 12‐week NEXTAC program but failed to show significant improvements in disability‐free survival as compared to observation alone. Further study on the progression of low muscle mass in the NEXTAC arm is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungPancreatic NeoplasmsLung NeoplasmsExercise TherapyNutrition TherapyHumansMaleFemaleAgedAged, 80 and overExerciseNutritional Status

Stichwörter der Autor:innen

cancer cachexiaelderlylow muscle massmultimodal interventionnon‐small cell lung cancerpancreatic cancer

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Division of Biomarker Discovery, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.

ORCID-Profile: Shuichi Mitsunaga, Tateaki Naito

Zitieren

APA

Mitsunaga, S., Naito, T., Imai, H., Kimura, M., Miura, S., Tanaka, H., Mizukami, T., Imoto, A., Kondoh, C., Okuyama, H., Ueno, M., Shiotsu, S., Inano, T., Chitose, H., Tatematsu, N., Okayama, T., Mouri, T., Sugiyama, M., Omae, K., …, & Takayama, K. (2025). A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non‐Small Cell Lung Cancer (NEXTAC‐TWO). Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13871

Vancouver

Mitsunaga S, Naito T, Imai H, Kimura M, Miura S, Tanaka H, et al. A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non‐Small Cell Lung Cancer (NEXTAC‐TWO). Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13871

BibTeX
@article{Mitsunaga2025,
  author = {Mitsunaga, Shuichi and Naito, Tateaki and Imai, Hisao and Kimura, Madoka and Miura, Satoru and Tanaka, Hisashi and Mizukami, Takuro and Imoto, Akira and Kondoh, Chihiro and Okuyama, Hiroyuki and Ueno, Makoto and Shiotsu, Shinsuke and Inano, Toshimi and Chitose, Haruka and Tatematsu, Noriatsu and Okayama, Taro and Mouri, Takako and Sugiyama, Miwa and Omae, Katsuhiro and Kawabata, Takanori and Mori, Keita and Takayama, Koichi},
  title = {A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non‐Small Cell Lung Cancer (NEXTAC‐TWO)},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13871}
}
Kostenlos starten →